IgAN (IgA Nephropathy)
Mohamed A. El-Shahawy, MD, MPH, MHA, FASN, CPI
Adjunct Clinical Professor of Medicine, Keck School of Medicine of USC
Director and Principal Investigator
IgAN (IgA Nephropathy)
Key Inclusion Criteria
- Adults aged 18 to 75 years
- Diagnosed by Kidney biopsy
Why Join the IGAN Trial?
– Access to highly experienced physicians and their trained research teams, no cost to participants.
– Clinical trials offer more care options for your condition, with access to new medicines at no cost.
– Participation is voluntary, and during informed consent process, you will learn all details about the study
– Help move science forward and improve human health, wellbeing, and quality of life.
– No cost to participate in this study.
Compensation
The Patient will receive $75.00 per each completed visit
If the patient completes all study visits, the total compensation would be $1,650.
Connect with Our Clinical Team
